Associations Urge CMS to Abandon Reimbursement Cuts for Low-Dose CT Scans
This Medical News Minute outlines efforts by a number of advocacy groups and medical associations urging the CMS to abandon proposed reimbursement cuts to low-dose CT screening for lung cancer.
In this Medical News Minute, developed exclusively for Cancer Network, Dr. Bobby Lazzara discusses efforts by a number of advocacy groups, health care systems, and medical associations urging the Centers for Medicare & Medicaid Services (CMS) to abandon proposed reimbursement cuts to low-dose CT screening for lung cancer.
The changes to reimbursement are laid out in the 2017 Hospital Outpatient Prospective Payment System (HOPPS) proposed rule.
Neoadjuvant Capecitabine Plus Temozolomide in Atypical Lung NETs
Read about a woman with well-differentiated atypical carcinoid who experienced a 21% regression in primary tumor size after 12 months on neoadjuvant capecitabine and temozolomide.
